Abvc biopharma provides 2023 pipeline update

Fremont, ca, feb. 28, 2023 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today provided an update to drug and medical device developments expected in 2023.
ABVC Ratings Summary
ABVC Quant Ranking